We just received data on a new analyst forecast for $CRDO. Barclays gave a rating of 'Overweight' for $CRDO.
$CRDO Analyst Ratings
Wall Street analysts have issued reports on $CRDO in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 04/22/2025
- Bank of America Securities issued a "Buy" rating on 12/03/2024
To track analyst ratings and price targets for $CRDO, check out Quiver Quantitative's $CRDO forecast page.
$CRDO Price Targets
Multiple analysts have issued price targets for $CRDO recently. We have seen 3 analysts offer price targets for $CRDO in the last 6 months, with a median target of $85.0.
Here are some recent targets:
- Vijay Rakesh from Mizuho Securities set a target price of $85.0 on 01/10/2025
- Tore Svanberg from Stifel Nicolaus set a target price of $85.0 on 01/08/2025
- Christopher Rolland from Susquehanna set a target price of $80.0 on 12/17/2024
$CRDO Congressional Stock Trading
Members of Congress have traded $CRDO stock 7 times in the past 6 months. Of those trades, 3 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CRDO stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 4 times. They made 0 purchases and 4 sales worth up to $60,000 on 03/04, 01/29.
- SENATOR MARKWAYNE MULLIN has traded it 3 times. They made 3 purchases worth up to $115,000 on 02/03, 01/02 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CRDO Insider Trading Activity
$CRDO insiders have traded $CRDO stock on the open market 187 times in the past 6 months. Of those trades, 0 have been purchases and 187 have been sales.
Here’s a breakdown of recent trading of $CRDO stock by insiders over the last 6 months:
- YAT TUNG LAM (Chief Operating Officer) has made 0 purchases and 63 sales selling 950,000 shares for an estimated $63,290,474.
- LIP BU TAN has made 0 purchases and 15 sales selling 750,000 shares for an estimated $55,678,983.
- CHI FUNG CHENG (Chief Technology Officer) has made 0 purchases and 83 sales selling 1,010,000 shares for an estimated $53,563,779.
- WILLIAM JOSEPH BRENNAN (Pres & Chief Executive Officer) has made 0 purchases and 10 sales selling 317,760 shares for an estimated $16,099,138.
- DANIEL W. FLEMING (Chief Financial Officer) has made 0 purchases and 8 sales selling 40,162 shares for an estimated $1,998,472.
- PANTAS SUTARDJA, has made 0 purchases and 5 sales selling 24,791 shares for an estimated $1,634,940.
- SYLVIA ACEVEDO sold 32,291 shares for an estimated $1,343,628
- JAMES LAUFMAN (Chief Legal Officer, Secretary) has made 0 purchases and 2 sales selling 18,000 shares for an estimated $1,075,220.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CRDO Hedge Fund Activity
We have seen 249 institutional investors add shares of $CRDO stock to their portfolio, and 126 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 3,297,763 shares (+23.2%) to their portfolio in Q4 2024, for an estimated $221,642,651
- JPMORGAN CHASE & CO removed 3,107,888 shares (-23.6%) from their portfolio in Q4 2024, for an estimated $208,881,152
- NORGES BANK added 1,744,412 shares (+inf%) to their portfolio in Q4 2024, for an estimated $117,241,930
- CAPITAL RESEARCH GLOBAL INVESTORS removed 1,650,409 shares (-29.9%) from their portfolio in Q4 2024, for an estimated $110,923,988
- D. E. SHAW & CO., INC. added 1,542,527 shares (+63.5%) to their portfolio in Q4 2024, for an estimated $103,673,239
- ALLIANCEBERNSTEIN L.P. added 1,305,594 shares (+299.9%) to their portfolio in Q4 2024, for an estimated $87,748,972
- WELLINGTON MANAGEMENT GROUP LLP removed 1,177,229 shares (-41.1%) from their portfolio in Q4 2024, for an estimated $79,121,561
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
